PepGen Shares 2023 Q2 Newsletter

July 21, 2023

On July 17, 2023, PepGen shared clinical updates for their Duchenne muscular dystrophy and Myotonic dystrophy type 1 studies and more.

Please click here to view a PDF of their Q2 newsletter.

Experience the magic of camp promise

Complete applications due April 3, 2023.